Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: A prospective, randomized study
Marion Haubitz(Klinikum Fulda), R. Brunkhorst(Klinikum Region Hannover), D. Schaumann(Medizinische Hochschule Hannover), Karl Koch(Goethe University Frankfurt), Hans-Joachim Schurek(St. Bonifatius Hospital), U. G�bel(Helios Hospital Berlin-Buch), Sebastian Schellong(Städtisches Klinikum Dresden)
Cited by 261
Related Papers
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
|New England Journal of Medicine|2009|2.6k
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
|Annals of the Rheumatic Diseases|2012|1k
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
|New England Journal of Medicine|2013|988